{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:25:33Z","timestamp":1784755533947,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autotaxin (ATX) is involved in the synthesis of lysophosphatidic acid. Both have recently been linked to cholestatic pruritus and liver injury. We aimed to investigate whether ATX is an indicator of cholestatic liver injury, health-related quality of life (HRQoL) and prognosis based on a group of 233 patients, 118 with primary biliary cholangitis (PBC) and 115 with primary sclerosing cholangitis (PSC). Patients were followed for 1\u201360 months, cumulative survival rates were calculated. ATX activity was significantly higher in both groups than in the 103 controls, particularly in patients with cirrhosis and in patients with longer disease duration. Ursodeoxycholic acid (UDCA) non-responders with PBC exhibited increased ATX activity. ATX activity was correlated with liver biochemistry, MELD, Mayo Risk scores and was associated with worse disease-specific HRQoL aspects. In both groups, Cox model analysis indicated that ATX was a negative predictor of survival. Increased ATX levels were associated with a 4-fold higher risk of death\/liver transplantation in patients with PBC and a 2.6-fold higher risk in patients with PSC. We conclude that in patients with cholestatic conditions, ATX is not only associated with pruritus but also indicates impairment of other HRQoL aspects, liver dysfunction and can serve as a predictor of survival.<\/jats:p>","DOI":"10.1038\/srep30847","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T09:32:21Z","timestamp":1470821541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases"],"prefix":"10.1038","volume":"6","author":[{"given":"Ewa","family":"Wunsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"BFsrep30847_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","volume":"139","author":"AE Kremer","year":"2010","unstructured":"Kremer, A. E. et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139, 1008\u20131018, 1018 (2010).","journal-title":"Gastroenterology"},{"key":"BFsrep30847_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1476-5381.2011.01622.x","volume":"165","author":"T Mutoh","year":"2012","unstructured":"Mutoh, T., Rivera, R. & Chun, J. Insights into the pharmacological relevance of lysophospholipid receptors. Br. J. Pharmacol. 165, 829\u2013844 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep30847_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.26909","volume":"60","author":"U Beuers","year":"2014","unstructured":"Beuers, U., Kremer, A. E., Bolier, R. & Elferink, R. P. Pruritus in cholestasis: facts and fiction. Hepatology 60, 399\u2013407 (2014).","journal-title":"Hepatology"},{"key":"BFsrep30847_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvq052","volume":"148","author":"K Nakanaga","year":"2010","unstructured":"Nakanaga, K., Hama, K. & Aoki, J. Autotaxin\u2013an LPA producing enzyme with diverse functions. J. Biochem. 148, 13\u201324 (2010).","journal-title":"J. Biochem."},{"key":"BFsrep30847_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.25748","volume":"56","author":"AE Kremer","year":"2012","unstructured":"Kremer, A. E. et al. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin and responds to therapeutic interventions. Hepatology 56, 1391\u20131400 (2012).","journal-title":"Hepatology"},{"key":"BFsrep30847_CR6","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1038\/srep06374","volume":"4","author":"M Krawczyk","year":"2014","unstructured":"Krawczyk, M. et al. Variant adiponutrin confers genetic protection against cholestatic itch. Sci. Rep 4, 6374, doi: 10.1038\/srep06374 (2014).","journal-title":"Sci. Rep"},{"key":"BFsrep30847_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.26365","volume":"58","author":"GF Mells","year":"2013","unstructured":"Mells, G. F. et al. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology 58, 273\u2013283 (2013).","journal-title":"Hepatology"},{"key":"BFsrep30847_CR8","doi-asserted-by":"publisher","first-page":"e103532","DOI":"10.1371\/journal.pone.0103532","volume":"9","author":"T Pleli","year":"2014","unstructured":"Pleli, T. et al. Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis\u2013a prospective cohort study. PLoS. One 9, e103532, doi: 10.1371\/journal.pone.0103532 (2014).","journal-title":"PLoS. One"},{"key":"BFsrep30847_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2141.2008.07325.x","volume":"143","author":"A Masuda","year":"2008","unstructured":"Masuda, A. et al. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br. J. Haematol. 143, 60\u201370 (2008).","journal-title":"Br. J. Haematol."},{"key":"BFsrep30847_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3177\/jnsv.44.809","volume":"44","author":"T Sasagawa","year":"1998","unstructured":"Sasagawa, T., Suzuki, K., Shiota, T., Kondo, T. & Okita, M. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. J. Nutr. Sci. Vitaminol. (Tokyo) 44, 809\u2013818 (1998).","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"BFsrep30847_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jdermsci.2014.01.010","volume":"74","author":"Y Shimizu","year":"2014","unstructured":"Shimizu, Y., Murao, K., Tanaka, T., Kubo, Y. & Tokumura, A. Increased lysophospholipase D activity of autotaxin in sera of patients with atopic dermatitis. J. Dermatol. Sci. 74, 162\u2013165 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"BFsrep30847_CR12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2014.10.041","volume":"62","author":"AE Kremer","year":"2015","unstructured":"Kremer, A. E. et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J. Hepatol. 62, 897\u2013904 (2015).","journal-title":"J. Hepatol."},{"key":"BFsrep30847_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MPG.0000000000001044","volume":"62","author":"AE Kremer","year":"2016","unstructured":"Kremer, A. E. et al. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders. J. Pediatr. Gastroenterol. Nutr. 62, 530\u2013535 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFsrep30847_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/gut.2005.065862","volume":"54","author":"A Jacoby","year":"2005","unstructured":"Jacoby, A. et al. Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 54, 1622\u20131629 (2005).","journal-title":"Gut"},{"key":"BFsrep30847_CR15","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/liv.12730","volume":"35","author":"J Raszeja-Wyszomirska","year":"2015","unstructured":"Raszeja-Wyszomirska, J. et al. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis. Liver Int. 35, 1764\u20131771 (2015).","journal-title":"Liver Int."},{"key":"BFsrep30847_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.27074","volume":"60","author":"E Wunsch","year":"2014","unstructured":"Wunsch, E. et al. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Hepatology 60, 931\u2013940 (2014).","journal-title":"Hepatology"},{"key":"BFsrep30847_CR17","unstructured":"Raszeja-Wyszomirska, J. et al. Assessment of health related quality of life in polish patients with primary biliary cirrhosis. Clin. Res. Hepatol. Gastroenterol. (2015)."},{"key":"BFsrep30847_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot, C. et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48, 871\u2013877 (2008).","journal-title":"Hepatology"},{"key":"BFsrep30847_CR19","doi-asserted-by":"publisher","first-page":"194857","DOI":"10.4061\/2011\/194857","volume":"2011","author":"M Jankowski","year":"2011","unstructured":"Jankowski, M. Autotaxin: its role in biology of melanoma cells and as a pharmacological target. Enzyme Res. 2011, 194857, doi: 10.4061\/2011\/194857 (2011).","journal-title":"Enzyme Res."},{"key":"BFsrep30847_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.bbadis.2016.01.012","volume":"1862","author":"R Bolier","year":"2016","unstructured":"Bolier, R. et al. Enteroendocrine cells are a potential source of serum autotaxin in men. Biochim. Biophys. Acta 1862, 696\u2013704 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep30847_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-9-71","volume":"9","author":"JM Wu","year":"2010","unstructured":"Wu, J. M. et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol. Cancer 9, 71, doi: 10.1186\/1476-4598-9-71 (2010).","journal-title":"Mol. Cancer"},{"key":"BFsrep30847_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2009.04.029","volume":"284","author":"S Jansen","year":"2009","unstructured":"Jansen, S. et al. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett. 284, 216\u2013221 (2009).","journal-title":"Cancer Lett."},{"key":"BFsrep30847_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.yexcr.2014.11.010","volume":"333","author":"R Leblanc","year":"2015","unstructured":"Leblanc, R. & Peyruchaud, O. New insights into the autotaxin\/LPA axis in cancer development and metastasis. Exp. Cell Res. 333, 183\u2013189 (2015).","journal-title":"Exp. Cell Res."},{"key":"BFsrep30847_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s11605-007-0322-9","volume":"11","author":"AB Cooper","year":"2007","unstructured":"Cooper, A. B., Wu, J., Lu, D. & Maluccio, M. A. Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J. Gastrointest. Surg. 11, 1628\u20131634 (2007).","journal-title":"J. Gastrointest. Surg."},{"key":"BFsrep30847_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cca.2014.03.006","volume":"433","author":"M Kondo","year":"2014","unstructured":"Kondo, M. et al. Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma. Clin. Chim. Acta 433, 128\u2013134 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"BFsrep30847_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","volume":"41","author":"N Watanabe","year":"2007","unstructured":"Watanabe, N. et al. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J. Clin. Gastroenterol 41, 616\u2013623 (2007).","journal-title":"J. Clin. Gastroenterol"},{"key":"BFsrep30847_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cca.2011.03.014","volume":"412","author":"H Nakagawa","year":"2011","unstructured":"Nakagawa, H. et al. Autotaxin as a novel serum marker of liver fibrosis. Clin. Chim. Acta 412, 1201\u20131206 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"BFsrep30847_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinre.2010.10.007","volume":"35","author":"AE Kremer","year":"2011","unstructured":"Kremer, A. E., Oude Elferink, R. P. & Beuers, U. Pathophysiology and current management of pruritus in liver disease. Clin. Res. Hepatol. Gastroenterol 35, 89\u201397 (2011).","journal-title":"Clin. Res. Hepatol. Gastroenterol"},{"key":"BFsrep30847_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","volume":"148","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield, G. M. et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology 148, 751\u2013761 (2015).","journal-title":"Gastroenterology"},{"key":"BFsrep30847_CR30","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.1038\/ncomms11248","volume":"7","author":"WJ Keune","year":"2016","unstructured":"Keune, W. J. et al. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling. Nat. Commun. 7, 11248, doi: 10.1038\/ncomms11248 (2016).","journal-title":"Nat. Commun."},{"key":"BFsrep30847_CR31","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 51, 237\u2013267 (2009).","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"BFsrep30847_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares, A., Caballeria, L. & Rodes, J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130, 715\u2013720 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep30847_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/clpt.2011.124","volume":"90","author":"J Trottier","year":"2011","unstructured":"Trottier, J., Caron, P., Straka, R. J. & Barbier, O. Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate. Clin. Pharmacol. Ther. 90, 279\u2013286 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFsrep30847_CR34","doi-asserted-by":"publisher","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","volume":"6","author":"J Trottier","year":"2011","unstructured":"Trottier, J. et al. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS. One 6, e22094, doi: 10.1371\/journal.pone.0022094 (2011).","journal-title":"PLoS. One"},{"key":"BFsrep30847_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","volume":"44","author":"J Trottier","year":"2012","unstructured":"Trottier, J. et al. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig. Liver Dis. 44, 303\u2013310 (2012).","journal-title":"Dig. Liver Dis."},{"key":"BFsrep30847_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/clpt.2013.122","volume":"94","author":"J Trottier","year":"2013","unstructured":"Trottier, J. et al. Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants and response to fenofibrate. Clin. Pharmacol. Ther. 94, 533\u2013543 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFsrep30847_CR37","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/gut.2005.065862","volume":"54","author":"A Jacoby","year":"2005","unstructured":"Jacoby, A. et al. Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 54, 1622\u20131629 (2005).","journal-title":"Gut"},{"key":"BFsrep30847_CR38","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.dld.2010.01.004","volume":"42","author":"L Montali","year":"2010","unstructured":"Montali, L. et al. A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis. Dig. Liver Dis. 42, 718\u2013723 (2010).","journal-title":"Dig. Liver Dis."},{"key":"BFsrep30847_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr.","year":"1992","unstructured":"Ware, J. E. Jr. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473\u2013483 (1992).","journal-title":"Med. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep30847","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:33:46Z","timestamp":1672868026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep30847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,14]]}},"alternative-id":["BFsrep30847"],"URL":"https:\/\/doi.org\/10.1038\/srep30847","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]},"assertion":[{"value":"27 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30847"}}